Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urine concentrations of vilanterol after inhaled administration of vilanterol/fluticasone furoate
2018-002529-48Phase 2Completed
- Sponsor
- Center for Aktiv Sundhed
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of fluticasone propionate + vilanterol (2 arms), sponsored by Center for Aktiv Sundhed. Primary endpoints: Primary: Urine concentration of vilanterol and metabolites after inhalation and Primary: Urine concentration of vilanterol and metabolites after 7 days of dosing. Started Jul 2018; status: completed.
02
Drugs
fluticasone propionate + vilanterol
Beyond the preview
Go deeper on 2018-002529-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002529-48.